Quercia, Romina
Di Perri, Giovanni
Pein, Carolina
Bodie, Jennifer
Singh, Ravi Shankar P.
Hendrick, Victoria
Boffito, Marta
Funding for this research was provided by:
Pfizer
Article History
Received: 21 December 2023
Accepted: 8 March 2024
First Online: 12 April 2024
Declarations
:
: Romina Quercia, Carolina Pein, Jennifer Bodie, Ravi Shankar P. Singh, and Victoria Hendrick are employees of and may hold stock or stock options in Pfizer. Giovanni Di Perri has received fees for lectures and participation in advisory boards from AbbVie, GS, ViiV Healthcare, GSK, Pfizer, AZ, Roche, MSD, and Janssen. Marta Boffito has consulted for or received speaker fees from ViiV Healthcare, Gilead, GlaxoSmithKline, Pfizer, Cypla, Mylan, and Janssen and has received research grants from Gilead, ViiV Healthcare, Mylan, Novavax, Janssen, Valneva, Moderna, and Roche.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals conducted by any of the authors.